ACTRN12615000907549终止未知
A Prospective MultiCentre Randomised Controlled Trial comparing unassisted Pelvic Floor Exercises with the PeriCoach Registered Trademark system assisted Pelvic Floor Exercises in the management of female stress urinary incontinence.
试验速览
- 阶段
- 未知
- 状态
- 终止
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 80 Years（—）
- 性别
- Female
入选标准
- •1.Study participant is a female and 18 years or older
- •2.Study participant is willing and able to sign an informed consent.
- •3.Study participant demonstrates stress urinary or mixed with predominantly stress, urinary incontinence of mild to moderate severity
- •4.Study participant willing and able to comply with follow-up activities.
- •5.Study participant has negative urine culture (using dipstick test) at baseline. (If leucocytes or nitrites present, send for culture. If negative or once treated, the study participant can be included).
- •6.Study participant has cognitive and manual capability to operate the device as determined by the investigator.
排除标准
- •1.Study participant has previously failed conservative incontinence treatment for at least 6 months. Conservative treatment includes one or more of the following:
- •a.Pelvic exercises and bladder training
- •b.Drug Therapy (All anticholinergics, SUI or antidepressants prescribed for treatment of SUI).
- •c.Current use of Biofeedback devices in conjunction with PFT
- •d.Transvaginal/Transcutaneous Electrical stimulation
- •2.Study participant refuses or is unable to sign the informed consent.
- •3.Study participant is pregnant or plans to be pregnant as verified by commercially available urine pregnancy test.
- •4.Study participant cannot comply with study requirements, including follow-up visits and tests.
- •5.Study participant is currently enrolled or plans to enrol in another investigational device or drug clinical trial or who has just completed an investigational study within 2 weeks.
- •6.Study participant has been determined to have severe urinary incontinence as confirmed on history taking or by the use of urethral plugs, intermittent or permanent urethral catheterisation.
- •7.Study participant has recent surgeries within 3 months or planned surgeries during the course of the study.
- •8.Study participant is unable to perform PFME due to an inability to perform Pelvic floor muscle contractions.
- •9.Study participant has a primary urge incontinence, mixed incontinence with a predominant urgency component, or urinary incontinence caused by factors other than stress incontinence.
- •10.Study participant has current pelvic floor prolapse grade 4 or requiring support device.
- •11.Study participant has had implantation of an artificial urinary sphincter prosthesis, sling, or other urogenital implant
- •12.Study participant has had pelvic implant including all mesh products.
- •13.Study participant has neurogenic bladder dysfunction that is not treatable or controllable by pharmacological or alternative methods.
- •14.Study participant has uncontrolled diabetes mellitus defined as persistent blood sugar level recordings of >12mmol/l (216. mg/dl) and a glycosylated haemoglobin (HbA1C) of >9% (75mmol/mol) over the preceding 3 months which may affect voiding function.
- •15.Study participant has current (within last 6 months) genito urinary or gynaecological cancer.
- •16.Study participant needs self-intermittent catheterization.
- •17.Study participant has a diagnosed disease (e.g., dementia) that might preclude the study participant from being able to recall or summarize her urinary status.
- •18.Study participant has a diagnosed disease or medical condition (e.g., Parkinson’s) that might preclude the study participant from being physically capable of manipulating the device.
- •19.Study participant has known allergy to device material (silicone).
- •20.Study participant has active (confirmed by laboratory urinalysis) or recurrent urinary tract infections (UTIs) where recurrent is defined as > 4 times over the past year.
- •21.Study participant has known anatomic abnormalities of the urethra or vagina judged to prevent placement and utilisation of the Investigational Device or is assessed as having an anatomic abnormality during the physical examination at screening).
研究者
相似试验
招募中
不适用
A Prospective, Multicenter Randomized Controlled Trial of Clinical Efficacy of Vertebral Acupuncture at Pressing Sensitive Acupoints in Treating Cervical Spondylosis of Mixed Type of Nerve Root and Vertebral ArteryITMCTR2000003915Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
已完成
4 期
Goal-directed Therapy for Patients Undergoing PancreaticoduodenectomyPancreatic cancerACTRN12616000538448Austin Hospital52
已完成
4 期
Goal-directed Therap for Patients Undergoing Major Liver ResectioSurgery - Other surgeryAnaesthesiology - AnaestheticsCancer - Liverliver cancerACTRN12616000172404Austin Hospital48
进行中（未招募）
1 期
PHOTODYNAMIC THERAPY VERSUS MICROPULSE LASER TREATMENT IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHYChronic central serous chorioretinopathyMedDRA version: 18.0 Level: PT Classification code 10063118 Term: Chorioretinopathy System Organ Class: 10015919 - Eye disordersEUCTR2012-004555-36-FRCentre Hospitalier Intercommunal de Créteil140
已完成
不适用
A prospective randomized controlled multicenter trial of catheter and papillotome: effect on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatographyPancreaticobiliary diseaseJPRN-UMIN000002572Hokkaido University Hospital, Department of Gastroenterology400